LLY

Eli Lilly and Company (LLY)

Last Price$746.2(4.9%)
Market Cap$907.2B
LTM Revenue
$40.9B
YoY Growth
+27.4%
3Y CAGR
+13.8%
5Y CAGR
+12.5%
Stock quality & Intrinsic value
4/10
38.0% overvalued

Eli Lilly and Company Revenue

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
Revenue
$13.9B
$14.6B
$15.7B
$18.6B
$20.4B
$21.8B
$23.1B
$24.3B
$22.6B
$23.1B
$19.6B
$20.0B
$21.2B
$22.9B
$21.5B
$22.3B
$24.5B
$28.3B
$28.5B
$34.1B
See the LLY
full fundamental analysis
View -->
Overvalued or undervalued?
Check the intrinsic value for LLY
Explore -->

Eli Lilly and Company (LLY) Revenue comparison analysis

Crunching data... Almost there!

Discover more Stock Ideas

Loved by
investors
worldwide
10K+
Investors use our platform
#1
Top value investing hub with all necessary tools
1K+
Experienced investors in our community
4.9
Average rating across all rating platforms

FAQ

1) What is Eli Lilly and Company's Revenue?

As of today, Eli Lilly and Company's last 12-month Revenue is $40.9B, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Eli Lilly and Company's Revenue growth rate?

Over the last year, Eli Lilly and Company's Revenue growth was 27.4%. The average annual Revenue growth rates for Eli Lilly and Company have been 17.0% over the past three years, 12.5% over the past five years.

3) Is Eli Lilly and Company's Revenue growth rate Good?

Over the last year, Eli Lilly and Company's Revenue growth was 27.4%, which is higher than industry growth of 0.1%. It indicates that Eli Lilly and Company's Revenue growth is Good.

4) How does Eli Lilly and Company's Revenue growth rate compare to its peers?

Over the last year, Eli Lilly and Company's Revenue growth was 27.4%, which is higher than peer median growth of 5.6%. The list of peers includes JNJ, SNY, MRK, PFE, ABBV, AZN, NVS, BMY, AMGN, GILD etc.